Psittacosis primary prevention

Revision as of 18:55, 9 August 2017 by Allisontu (talk | contribs)
Jump to navigation Jump to search

Psittacosis Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Psittacosis from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Chest X Ray

CT

MRI

Echocardiography or Ultrasound

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Psittacosis primary prevention On the Web

Most recent articles

cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Psittacosis primary prevention

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Psittacosis primary prevention

CDC on Psittacosis primary prevention

Psittacosis primary prevention in the news

Blogs on Psittacosis primary prevention

Psittacosis

Risk calculators and risk factors for Psittacosis primary prevention

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]:Associate Editor(s)-in-Chief: Omodamola Aje B.Sc, M.D. [2]

Overview

Effective measures for the primary prevention of psittacosis include avoidance of exposure to birds that may carry this bacteria, such as imported parakeets. Medical problems that lead to a weak immune system also increase the risk for this disease and should be treated appropriately.

Primary prevention

Since the major means of transmission of psittacosis is through infected birds:

  • Infected birds should be treated with antibiotics under veterinary guidance. Doxycycline is considered superior to chlortetracycline.[1]
  • It is necessary to clean all potentially contaminated areas, first with removal of organic material, then disinfection due to the persistence of the C. psittaci.
  • The use of protective equipment including gloves, an N95 mask (respirator), eye wear, and surgical cap while disinfecting is recommended.
  • There are no human vaccines available yet for C. psittaci, but encouraging results have been achieved in poultry with DNA vaccines encoding C. psittaci MOMP.[2]

References

  1. Smith KA, Bradley KK, Stobierski MG, Tengelsen LA, National Association of State Public Health Veterinarians Psittacosis Compendium Committee (2005). "Compendium of measures to control Chlamydophila psittaci (formerly Chlamydia psittaci) infection among humans (psittacosis) and pet birds, 2005". J Am Vet Med Assoc. 226 (4): 532–9. PMID 15742693.
  2. Ogren SO, Hökfelt T, Kask K, Langel U, Bartfai T (1992). "Evidence for a role of the neuropeptide galanin in spatial learning". Neuroscience. 51 (1): 1–5. PMID 1281521.